A novel pre-clinical strategy to deliver antimicrobial doses of inhaled nitric oxide

Effective treatment of respiratory infections continues to be a major challenge. In high doses (≥160 ppm), inhaled Nitric Oxide (iNO) has been shown to act as a broad-spectrum antimicrobial agent, including its efficacy in vitro for coronavirus family. However, the safety of prolonged in vivo implem...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaelsen, Vinicius S., Ribeiro, Rafaela V. P., Brambate, Edson, Ali, Aadil, Wang, Aizhou, Pires, Layla, Kawashima, Mitsuaki, Zhang, Yu, Gazzalle, Anajara, Keshavjee, Shaf, Del Sorbo, Lorenzo, Cypel, Marcelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513841/
https://www.ncbi.nlm.nih.gov/pubmed/34644318
http://dx.doi.org/10.1371/journal.pone.0258368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513841/
https://www.ncbi.nlm.nih.gov/pubmed/34644318
http://dx.doi.org/10.1371/journal.pone.0258368

Ejemplares similares